- Home
- MNPR vs TTSH Comparison
MNPR vs TTSH Comparison
Compare MNPR & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- TTSH
- Stock Information
- Founded
- MNPR 2014
- TTSH 1985
- Country
- MNPR United States
- TTSH United States
- Employees
- MNPR N/A
- TTSH N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- TTSH Blank Checks
- Sector
- MNPR Health Care
- TTSH Finance
- Exchange
- MNPR Nasdaq
- TTSH Nasdaq
- Market Cap
- MNPR 248.8M
- TTSH 296.1M
- IPO Year
- MNPR 2019
- TTSH N/A
- Fundamental
- Price
- MNPR $35.71
- TTSH $5.91
- Analyst Decision
- MNPR Strong Buy
- TTSH
- Analyst Count
- MNPR 7
- TTSH 0
- Target Price
- MNPR $62.00
- TTSH N/A
- AVG Volume (30 Days)
- MNPR 20.7K
- TTSH 37.0K
- Earning Date
- MNPR 08-12-2025
- TTSH 08-07-2025
- Dividend Yield
- MNPR N/A
- TTSH N/A
- EPS Growth
- MNPR N/A
- TTSH N/A
- EPS
- MNPR N/A
- TTSH N/A
- Revenue
- MNPR N/A
- TTSH $340,228,000.00
- Revenue This Year
- MNPR N/A
- TTSH N/A
- Revenue Next Year
- MNPR N/A
- TTSH N/A
- P/E Ratio
- MNPR N/A
- TTSH N/A
- Revenue Growth
- MNPR N/A
- TTSH N/A
- 52 Week Low
- MNPR $2.15
- TTSH $4.62
- 52 Week High
- MNPR $54.30
- TTSH $7.75
- Technical
- Relative Strength Index (RSI)
- MNPR 43.81
- TTSH 39.31
- Support Level
- MNPR $30.51
- TTSH $5.72
- Resistance Level
- MNPR $36.51
- TTSH $6.55
- Average True Range (ATR)
- MNPR 3.33
- TTSH 0.34
- MACD
- MNPR -0.95
- TTSH -0.05
- Stochastic Oscillator
- MNPR 37.55
- TTSH 18.27
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About TTSH Tile Shop Holdings Inc.
Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.